Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

The initiative, focused on investigators from Memorial Sloan-Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.

In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development.

A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Dr. DeAngelis has been elected to the Institute of Medicine (IOM), considered one of the highest honors in the field of health and medicine.

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.